$95M to be Allocated from NJ Opioid Fund to Battle Crisis

On Feb 16, 2024

Gov. Phil Murphy announced the allocation of over $95 million from New Jersey’s Opioid Recovery and Remediation Fund to support critical programs tackling the opioid crisis, connecting New Jerseyans with tools to reduce overdoses and other harms of substance use, and supporting the treatment and recovery of residents struggling with substance use disorders. At the recommendation of the state’s Opioid Recovery and Remediation Advisory Council and with extensive input from the public, six programs addressing four priority areas – harm reduction, prevention and recovery support, treatment, and housing – have been identified to receive funding over the next two to three years.

“We are making a historic investment in life-saving and life-changing programs that will connect those suffering from a substance use disorder with the help they need. By bringing together service providers, subject matter experts, and those who have experienced firsthand the impact of the opioid crisis, we have identified key programs to maximize the State’s Opioid Recovery and Remediation Fund,” said Murphy.

This funding will be invested in initiatives to bolster services and address the needs of those who have been adversely impacted by the opioid crisis:

• $24 million over two years to expand harm reduction and drug user health services at authorized Harm Reduction Centers, and to deploy harm reduction supplies through partner organizations in high-need areas. This will support startup and expansion by the 32-and-counting Harm Reduction Center sites authorized under P.L. 2021, c.396 as implemented in 2023;
• $17.505 million over three years to expand operations at New Jersey’s 22 Community Peer Recovery Centers, which provide treatment information and other resources in supportive, substance-free environments;
• $9.025 million over three years to replace and add mobile units providing Medication Assisted Treatment (MAT) services in the community;
• $19.5 million over three years to scale remote referrals to enable 24/7 connections to care from vetted treatment providers and harm reduction services. This statewide expansion aims to build upon federal funding that DOH is using to pilot the Medication for Addiction Treatment & Electronic Referrals (MATTERS NJ) platform in four counties;
• $17 million over three years to bolster the supported housing continuum, including emergency shelter beds for immediate needs, short-term rental subsidies, transitional housing beds, and permanent housing assistance; and
• $8.1 million over three years to expand the New Jersey Keeping Families Together program, which supports parents with opioid use disorder through housing vouchers and rental subsidies, case management, linkage to community services, and therapeutic supports.

The Departments of Human Services, Health, and Children and Families will administer these initiatives. Meanwhile, New Jersey will continue to address new challenges in the opioid response including the emerging threat of fentanyl adulterated or associated with xylazine (FAAX) in the drug supply nationwide. In 2024, $500,000 will be used to deploy wound care supplies, hygiene kits, and – through authority under P.L.2023, c.224 enacted in January – xylazine testing supplies.

Collectively, this spending builds on the hundreds of millions of state and federal dollars that the Murphy administration has already invested to reduce harm and save lives through innovation and evidence-based initiatives across state agencies.

“We are incredibly proud to announce our initial spending recommendations and decisions, which invest significantly and strategically in initiatives designed to end and recover from the opioid epidemic in New Jersey,” said Sarah Adelman, New Jersey Human Services commissioner and chairperson of the Advisory Council. “We are hopeful these initiatives will have a meaningful impact on individuals and families affected by opioid use. These recommendations serve as the foundation on which we will continue to build in response to the ever evolving and multifaceted disease of addiction.”

The Advisory Council, which was established by Executive Order No. 305, and codified by P.L.2023, c.25, is tasked with making recommendations for the administration’s consideration regarding the prioritization and effective use of the state’s share of the nationwide settlement agreements with several opioid manufacturers and distributors for their contributions to the ongoing opioid epidemic. The State of New Jersey, along with eligible counties and municipalities, will receive over $1 billion in settlement funds over the next two decades. As a result, the Advisory Council is also undertaking longer-term strategic planning.

More details about the opioid settlements spending process in New Jersey and any future opportunities to provide input will be posted here.

To access more business news, visit NJB News Now.

Related Articles: